Reason: CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Distributed: Nationwide in the US and Puerto RicoReason: CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Distributed: Nationwide in the US and Puerto RicoReason: CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Distributed: Nationwide in the US and Puerto RicoReason: Subpotent Drug: Out of specification for assay
Distributed: NationwideReason: Lack of Assurance of Sterility
Distributed: Nationwide within the United StatesReason: Lack of Assurance of Sterility
Distributed: Nationwide within the United StatesReason: Lack of Assurance of Sterility
Distributed: Nationwide within the United StatesReason: Lack of Assurance of Sterility
Distributed: Nationwide within the United StatesReason: Failed Dissolution Specifications: Out of specification for dissolution.
Distributed: Nationwide in the U.S.Reason: CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex
Distributed: Nationwide in the USA